Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
22 hedge funds and large institutions have $7.21M invested in Biocept, Inc. in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 7 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
27% more capital invested
Capital invested by funds: $5.69M → $7.21M (+$1.52M)
0% more funds holding
Funds holding: 22 → 22 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
47% less call options, than puts
Call options by funds: $937K | Put options by funds: $1.78M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Belvedere Trading
Chicago,
Illinois
|
+$457K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$424K |
| 3 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$414K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$273K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$236K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$493K |
| 2 |
Morgan Stanley
New York
|
-$293K |
| 3 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$138K |
| 4 |
Man Group
London,
United Kingdom
|
-$74K |
| 5 |
Bank of New York Mellon
New York
|
-$72K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| – | -$363 | -2 | Closed |
|
|
AWC
27
Abundance Wealth Counselors
State College,
Pennsylvania
| – | +$182 | +1 | New |
|
28
Bank of America
Charlotte,
North Carolina
| – | +$363 | +2 | New |
|
BIOC Hedge Fund Activity: Q1 2021 in Review
22 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2021, worth a combined $7.21M — up 27% from $5.69M a quarter earlier.
Fund positioning in BIOC was balanced in Q1 2021: 7 funds opened new positions, 7 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Belvedere Trading, opening a new position worth an estimated $457K. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $493K sold.
- 22 institutional investors held Biocept, Inc. (BIOC) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $7.21M of Biocept, Inc. stock for Q1 2021, up 27% quarter-over-quarter.
- 7 funds opened new Biocept, Inc. positions in Q1 2021 and 7 closed out, a net change of 0 holders.
- The largest Biocept, Inc. buyer in Q1 2021 was Belvedere Trading, an estimated $457K added.
- The largest Biocept, Inc. seller in Q1 2021 was Driehaus Capital Management, an estimated $493K sold.
Based on aggregated 13F filings for Q1 2021.